[
  {
    "text": "[Section 3] pattern discovery safety studies disparate distributed heterogeneous ehr systems www salusproject eu white p aper p ublished s alus consortium 3 x0ca brief overview salus interoperability approach introduction salus aims create necessary semantic interoperability infrastructure enable secondary use ehr data efficient effective way enabling pro active post market safety studies addressing need effective post market surveillance methods process approving pharmaceutical agents use humans usually hinges establishing efficacy agent usually achieved appropriately designed rigorously analyzed randomized clinical trials whilst certain safety aspects established evaluation development program ranging animal studies dedicated large trials approved agents limited data ensuring safety product approval include example risk rare events identified clinical trials limited size delayed effects drug limited duration trials furthermore clinical trials usually exclusion criteria e g elderly pregnant",
    "metadata": {
      "chunk_id": "3fd63e4f5518d69562404c97f60c6ca2",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 4] include example risk rare events identified clinical trials limited size delayed effects drug limited duration trials furthermore clinical trials usually exclusion criteria e g elderly pregnant women little data certain groups available prior approval ultimately use agent pattern drug use clinical trials necessarily reflect real world use drug reaches population impact safety reasons pre market safety analysis clinical trials remains vital considerable attention improving reporting collection post market data current post market safety surveillance reporting activities largely based reports suspected adverse drug reactions sent regulatory bodies medical professionals countries patients spontaneous reporting remains cornerstone pharmacovigilance regulator environment indispensable signal detection recent examples drug withdrawals1 uncommon adverse events millions patients exposed need effective proactive surveillance reinforced main problems current drug surveillance system",
    "metadata": {
      "chunk_id": "fcdd1b7e1a87391cdc5b4cda3df9f054",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [
          "regulatory"
        ],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 12.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 5] signal detection recent examples drug withdrawals1 uncommon adverse events millions patients exposed need effective proactive surveillance reinforced main problems current drug surveillance system underreporting estimated 5% adverse drug events ades reported spontaneous reporting2 partially fact overloaded medical personnel reporting priority issue detecting adverse events straightforward overlooked possible estimate number patients taking drug spontaneous reports readily enable quantification risk benefit risk profile product determined evident whilst proactive post market surveillance methods needed create additional burden health care provider patient 1 philadelphia inquirer astrazeneca abandons blood thinner citing risk feb 15 2006 bates d w evans r s murff h stetson p d pizziferri l hripcsak g 2003 detecting adverse events information technology journal american medical informatics association 10 2 115 xe2 x80 x93128 2 www salusproject eu white p aper p ublished s alus consortium",
    "metadata": {
      "chunk_id": "f0ffd956bc91d2fe4187b08173b29721",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 7] timely feedback regulatory bodies automatic ehr supported adverse event reporting xef x82 xa7 strengthening current signal detection processes pharmacovigilance centers tracing case reports corresponding patient records allow actual incidence rates computed provide additional information extended parts underlying medical history patient xef x82 xa7 enabling real time screening multiple distributed heterogeneous ehrs early detection ade signals facilitates proactive safety monitoring complementary approach reactive signal detection based spontaneous reports xef x82 xa7 enabling sustainable scalable ehr data use facilitating wide scale outcome health effectiveness research able observe selected cohorts patients extended period time screening multiple distributed heterogeneous ehr systems important advantage ehr data offer potential quantification contextualization risk safety studies help determine benefit risk profile drug ultimately determines use drug population facilitate wide scale",
    "metadata": {
      "chunk_id": "479cdf1fb7ac04cfcd7e6267e0999cf9",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [
          "regulatory"
        ],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 12.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 8] advantage ehr data offer potential quantification contextualization risk safety studies help determine benefit risk profile drug ultimately determines use drug population facilitate wide scale proactive post market safety studies need new capacity enabling access data locked multiple different heterogonous ehr systems interoperability architecture interoperability architecture enable execution proactive post market surveillance studies pharmaceutical companies regulatory bodies cooperation heterogeneous distributed ehr systems salus project3 r d project co financed european commission s 7th framework programme fp7 aims create necessary semantic functional interoperability infrastructure enable secondary use ehr data efficient effective way reinforcing post market safety studies addressing challenges presented 3 salus project scalable standard based interoperability framework sustainable pro active post market safety studies http www salusproject eu www salusproject eu white p aper p",
    "metadata": {
      "chunk_id": "ddd83b52adcb71b05a7e1eee21c9f9f9",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [
          "regulatory"
        ],
        "technical": [],
        "financial": [],
        "operational": [
          "locked"
        ]
      },
      "risk_score": 21.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 9] challenges presented 3 salus project scalable standard based interoperability framework sustainable pro active post market safety studies http www salusproject eu www salusproject eu white p aper p ublished s alus consortium 5 x0ca brief overview salus interoperability approach salus interoperability architecture challenges address achieving syntactic functional interoperability ehr systems clinical research systems salus approach provide functional interoperability profiles open source tools query ehr data ade identification ade reporting signal followup studies sub scribe clinical data selected cohort patients signal detection outcome research distributed ehrs interoperability profiles aim enable ehr systems clinical research systems running post market safety studies communicate exchange data order enable collaborating systems interpret queries resulting clinical data exchanged meaningfully accurately producing useful results need semantic interoperability layer built functional",
    "metadata": {
      "chunk_id": "57742d861f6bb273f5ecb286bab3ece2",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 10] data order enable collaborating systems interpret queries resulting clinical data exchanged meaningfully accurately producing useful results need semantic interoperability layer built functional interoperability profiles pre requisites semantic interoperability architecture common core data set interest data analysis tools post marketing safety studies role salus semantic interoperability framework semantically mediating clinical data represented syntactically different semantically equivalent ehr content models making use core set common data elements common denominator facilitated ontological framework following subsections analyze need functional semantic interoperability solutions enabling post market safety studies ehrs present salus approach realize providing functional interoperability profiles ehr systems clinical research systems enabling proactive post market safety studies achieving syntactic functional interoperability ehr systems clinical research necessary condition",
    "metadata": {
      "chunk_id": "e8e8b782d840da78b471e1996a21dd9f",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 11] profiles ehr systems clinical research systems enabling proactive post market safety studies achieving syntactic functional interoperability ehr systems clinical research necessary condition enabling semantic interoperability requirements syntactic functional interoperability profiles enabling proactive post market safety studies summarized follows xef x82 xb7 different rule based intelligent data analysis algorithms plugged available ehrs detect ades checking administered drugs laboratory test results vital signs findings diagnoses report medical practitioners order facilitate detection reporting ades standard based protocols needed specify data screened machine processable manner feed data intelligent data analysis algorithms send suspected ade list medical practitioners seamlessly ehr session way easier integrate different ade detection tools heterogeneous ehr systems order conduct scalable distributed post market safety studies xef x82 xb7 detection ades enabling mechanisms",
    "metadata": {
      "chunk_id": "d2787e953336fc069e2e58e8e42736e5",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 13] x82 xb7 spontaneous reports report ade events information related percentage patients drug experienced ades e denominator data missing reports fail account important information patient underlying medical conditions co medication ideal system adverse drug reaction surveillance combine strength case reports ehrs4 standard interfaces needed tracing case reports corresponding patient records query ehrs enable absolute reporting rates computed retrieve additional information extended parts underlying medical history patient figure 2 salus enables exploratory signal detection epidemiological research studies heterogeneous ehrs 4 g niklas xc3 xa9n ralph edwards opportunities challenges adverse drug reaction surveillance electronic patient records pharmacovigilance review volume 4 number 1 february 2010 www salusproject eu white p aper p ublished s alus consortium 7 x0ca brief overview salus interoperability approach xef x82 xb7 strengthening available spontaneous reporting step forward post",
    "metadata": {
      "chunk_id": "105eb3ccc9de0b24e565e0471ea84803",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 14] 2010 www salusproject eu white p aper p ublished s alus consortium 7 x0ca brief overview salus interoperability approach xef x82 xb7 strengthening available spontaneous reporting step forward post marketing safety studies order realize near real time proactive post market safety studies needs mechanism screening available heterogeneous disparate ehrs specified time period adverse event signal detection conducting observational studies validation suspected signals carrying outcome research long term effects drugs need machine processable mechanism identify target patient population eligibility checking details clinical data collected exchange mechanism feed pseudonymized patient data common registry syntactic functional interoperability achieved systems capable communicating exchanging data specifying communication protocols data formats addressing requirements proactive post market safety studies summarized need standardized interfaces ehr systems clinical research systems xef x82 xb7",
    "metadata": {
      "chunk_id": "d03395c2a639cd230a136100a4666e2b",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 15] specifying communication protocols data formats addressing requirements proactive post market safety studies summarized need standardized interfaces ehr systems clinical research systems xef x82 xb7 specify eligibility criteria select patients specific post market safety study xef x82 xb7 specify clinical data requested intelligent data analysis tool ade detection signal detection outcome research fed clinical data registry selected group patients xef x82 xb7 transfer specified clinical data clinical data registries selected patients xef x82 xb7 query underlying ehrs support follow studies signal detection xef x82 xb7 query underlying ehrs fill ade reports ade detected define standardized interfaces salus project follow xe2 x80 x9cprofiling xe2 x80 x9d approach profile concept aims eliminate need bilateral agreement information exchange partners defining standard set messages documents choreographies business rules constraints analyzing selected use case scenarios required",
    "metadata": {
      "chunk_id": "4436be260d97c2fe7f54e6d2e3e22502",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [
          "fine"
        ],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 12.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 16] aims eliminate need bilateral agreement information exchange partners defining standard set messages documents choreographies business rules constraints analyzing selected use case scenarios required transactions determined best suitable standards enabling transactions chosen salus functional interoperability profiles based available initiatives achieving syntactic interoperability use ehrs clinical trial execution ihe retrieve form data capture rfd 5 clinical research data capture crd 6 drug safety content profile dsc 7 profiles hl7 clinical research filtered query service function model crfq sfm 8 suitable proposing necessary extensions enabling standard based interoperability architecture post market surveillance 5 ihe retrieve form data capture profile http wiki ihe net index php title retrieve form data capture ihe clinical research data capture profile profile http wiki ihe net index php title clinical research data capture 7 ihe drug safety content profile http wiki ihe net",
    "metadata": {
      "chunk_id": "b9bf2a37fc5ab40374705d7a2c5f7f7e",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 17] retrieve form data capture ihe clinical research data capture profile profile http wiki ihe net index php title clinical research data capture 7 ihe drug safety content profile http wiki ihe net index php title drug safety content 8 hl7 clinical research filtered query service function model crfq sfm http www hl7 org special committees rcrim projects cfm action edit projectnumber 541 6 www salusproject eu white p aper p ublished s alus consortium 8 x0ca brief overview salus interoperability approach providing semantic interoperability framework enabling proactive post market safety studies ability computer systems exchange information addressing syntactic functional interoperability requirements semantic interoperability needed automatically interpret information exchanged meaningfully accurately order produce useful results 9 semantic interoperability prerequisite enabling secondary use ehr data post market safety studies clinical data consistently captured ehr systems analyzed",
    "metadata": {
      "chunk_id": "df64a77798e5cce0083925b174deb53f",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 21] ontology aimed act common denominator exchanging clinical data required proactive post market patient safety studies clinical care research systems ontology shall based existing standards clinical care research domains existing data sets able create common harmonized ontology systematic scalable way serve needs salus use cases following activities aimed carried based methodology xef x82 xb7 identifying clinical information requirements selected salus use cases related transactions enabling safety research aim agree design content models message payloads exchanged based prominent clinical data exchange standards clinical care research domains cdisc odm models cda templates cen iso 13606 archetypes important initiative respect intended cen iso semantic interoperability artefact modeling standard siams 11 siams approach provides generic neutral standard approach defining models use specific cen iso 13606 openehr hl7 cda syntax generic model use translated 13606 archetypes openehr",
    "metadata": {
      "chunk_id": "c351f1a56edec71c762a0153508f8cb9",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 22] standard siams 11 siams approach provides generic neutral standard approach defining models use specific cen iso 13606 openehr hl7 cda syntax generic model use translated 13606 archetypes openehr archetypes hl7v3 cda based content templates necessary aim develop generic editor clinical information models cims defining models use translated different standards like hl7 cda cdisc odm cen iso 13606 xef x82 xb7 based information requirements expressed content models identifying core common data element cde set meaningful fragments building blocks create content models provide necessary tools create select adapt manage cdes core data set conformance iso iec 11179 standard metadata registries12 xef x82 xb7 building harmonized patient safety study ontology core cde set evolving ontology act common semantic dictionary clinical terms exchanged ehr systems clinical research systems supporting ontology fragments domain specific ontologies drug ontologies specific disease ontologies added common",
    "metadata": {
      "chunk_id": "122987aef7a2c2d356d816a94f98d541",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  },
  {
    "text": "[Section 23] semantic dictionary clinical terms exchanged ehr systems clinical research systems supporting ontology fragments domain specific ontologies drug ontologies specific disease ontologies added common ontology providing necessary semantic interlinkages ontology fragments cover related fragments terminologies clinical care research domains like meddra loinc atc snomed ct icd 10 whodd salus build semantic metadata registry managing common data elements conformance iso iec 11179 standard 11 cen iso semantic interoperability artefact modeling standard siams initiative http www en13606 org wiki index php title detailed clinical models archetype modeling 12 iso iec 11179 standard metadata registries http metadata stds org 11179 www salusproject eu white p aper p ublished s alus consortium 10 x0ca brief overview salus interoperability approach harmonized ontology salus semantic mediation framework aims enable underlying clinical research clinical care systems communicate existing domain",
    "metadata": {
      "chunk_id": "a28c61e378d3dcce0a2d16b5fd54dc60",
      "entities": {
        "email": [],
        "crypto_address": []
      },
      "risk_features": {
        "regulatory": [],
        "technical": [],
        "financial": [],
        "operational": []
      },
      "risk_score": 0.0,
      "source": "SaluS.txt"
    }
  }
]